Cosmetic procedures were once reserved for middle-aged women and often involved surgery. Today they are increasingly sought after by girls who want the photoshopped faces of their favorite social media influencer and by an increasing number of men who want fewer wrinkles, fuller lips and sharper jaws. Globally, more than 14 million non-surgical procedures were performed in 2020, including during the pandemic, compared to less than 13 million two years earlier. Increasingly, scalpels give way to syringes.
Research and Markets, an analytics firm, estimates that global sales of non-invasive cosmetic treatments, currently at around $ 60 billion, could more than triple by 2030. Much of this growth will come from injectable products. These include Botox and other substances that freeze the facial muscles, as well as dermal fillers that plump the soft tissues. Demand was fueled by the proliferation of selfies and, during the pandemic, high-resolution video calling. Snapchat and Instagram filters give users a preview of what they might look like with a “liquid face lift” generated by the filler. The contrast to what they see on the no-nonsense Zoom can be stark.
Statistics show recurring revenue for injectors
In 2020, about 2.4 million injectable procedures were performed, even with the closure of some medical and cosmetic offices due to the pandemic. In Germany, there were about 700,000 such treatments in 2020. Demand reached half a million procedures that year in Brazil, although people generally have less disposable income.
In Asia, demand is particularly strong for what is known as “prejuvenation” – the desire to stop wrinkles and other signs of aging before they begin with cosmetic procedures in adolescence and early childhood.
These statistics mean recurring revenue for medical and dental practices, spas, and beauty treatment centers around the world offering injectable products. Since botox and dermal filler treatments need to be done every few months, happy customers will come back again and again and a younger start means more business for the injectors.
According to consulting firm McKinsey, investors have invested more than $ 3 billion in more than 400 cosmetic clinics over the past 5 years. US pharmaceutical company AbbVie paid $ 63 billion in 2020 for Allergan, the company that makes Botox and Juvederm fillers and controls nearly half of the injectables market.
New products from companies in South Korea, France and elsewhere threaten Allergan’s dominance, but only serve to increase the demand and availability of injectables.
Some fillers now contain hyaluronic acid, an ingredient familiar to many people who use skin care products and therefore less daunting than Botox and other fillers. The fillers are even made from the patient’s blood or stem cells, which is even more appealing to some consumers.
One caveat, though: The growing desire for injectables among young people has drawn the attention of regulators in some jurisdictions. In England, for example, the government has banned treatment for children under 18 and now requires all injectors to obtain a license. In the United States, each state sets its own rules for Botox and fillers, which vary widely.
If you are a cosmetic or medical professional ready to gain your share of the injectables market, Dentox can help you by offering botox and dermal filler courses on your terms: in person, live online or on demand. All Dentox training courses are hands-on, even remotely conducted, and are taught by America’s most experienced injectable instructor, Dr. Howard Katz. Find out more or register now for Dentox training.
Black American women are receiving Botox more than ever
Dermatologist Corey L. Hartman, 46, receives Botox every three to four months and did so from his residence 15 years ago. “If I have heartburn and I know there is a cure for heartburn, I will go and get the cure for heartburn. If I have a line on my face that I don’t like and I know there is a solution for that line, then I’m going to get it if I can afford it, ”says Hartman. As the founder and medical director of Skin Wellness Dermatology in Birmingham, Alabama, Hartman said he has seen a huge increase in interest, discussion and follow-up for Botox and other injectables among black and brown patients.
–
